Copyright
©The Author(s) 2021.
World J Hepatol. May 27, 2021; 13(5): 543-556
Published online May 27, 2021. doi: 10.4254/wjh.v13.i5.543
Published online May 27, 2021. doi: 10.4254/wjh.v13.i5.543
Figure 2 Estimated 5- and 3-year survival [S (t)] from the bile-acids score and non- bile-acids score models.
A: The relationship between estimated 5- and 3- year survival probability [S (t)] as a function of bile-acids score (BAS); B: The relationship between estimated 5- and 3- year survival probability [S (t)] as a function of non-BAS. Q1, Q2, and Q3 are 25th, 50th, and 75th percentiles of the population, respectively. BAS: Bile-acids score.
- Citation: Alamoudi JA, Li W, Gautam N, Olivera M, Meza J, Mukherjee S, Alnouti Y. Bile acid indices as biomarkers for liver diseases II: The bile acid score survival prognostic model. World J Hepatol 2021; 13(5): 543-556
- URL: https://www.wjgnet.com/1948-5182/full/v13/i5/543.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i5.543